DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Lotan, Yair
Shah, Jay B.
Krishna, Viswesh
Launer, Bryn
Krishna, Vrishab
Shingi, Siddhant
Gordetsky, Jennifer
Gerald, Thomas
Shkolyar, Eugene
Hayne, Dickon
Redfern, Andrew
Spalding, Lisa
Stewart, Courtney
Narayanan, Vikram
Patil, Dattatreya
Packiam, Vignesh T.
Rajan, Anand
O'Donnell, Michael A.
Baekelandt, Loic
Fernandez, Mario I.
Schultz, Marcela
Hensley, Patrick J.
Allison, Derek B.
Taylor, John A.
Hamza, Ameer
Nimgaonkar, Vivek
Tiu, Ekin
Vaickus, Louis J.
Sonawane, Snehal
Miller, Daniel L.
Vrabac, Damir
Abuzeid, Waleed M.
Joshi, Anirudh
Chang, Sam S.
Williams, Stephen B.
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD27-12
引用
收藏
页码：E555 / E556
页数：2
相关论文
共 50 条
  • [21] Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated disease
    Miyake, Makito
    Nishimura, Nobutaka
    Fujii, Tomomi
    Fujimoto, Kiyohide
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (11) : 944 - 957
  • [22] STING PATHWAY MOLECULES DO NOT PREDICT BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER
    Lombardo, Kara
    Epstein, Gabriel
    Liu, James L.
    Choi, Woonyoung
    Kates, Max
    McConkey, David
    Matoso, Andres
    Bivalacqua, Trinity J.
    JOURNAL OF UROLOGY, 2021, 206 : E1131 - E1131
  • [23] Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
    de Jong, Joep J.
    Hendricksen, Kees
    Rosier, Marloes
    Mostafid, Hugh
    Boormans, Joost L.
    BLADDER CANCER, 2018, 4 (04) : 395 - 401
  • [24] Predictors of response to BCG therapy in non-muscle invasive bladder cancer
    Radovanovic, Milan
    Petrovic, Milos
    Santric, Veljko
    Zubelic, Aleksa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (1-2) : 113 - 116
  • [25] Non-muscle invasive bladder cancer biomarkers beyond morphology
    De Carlo, Camilla
    Valeri, Marina
    Corbitt, Devin Nicole
    Cieri, Miriam
    Colombo, Piergiuseppe
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] OUTCOMES OF PATIENTS TREATED WITH ADDITIONAL BCG FOLLOWING A BCG UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER DIAGNOSIS
    Christopher, Guske
    Joshua, Linscott
    Christian, Harrs
    Pierre, Ghobrial
    Daniel, Calkins
    Barry, Sirard R.
    Behzad, Jazayeri
    Lexiaochuan, Wen
    Justin, Miller
    Xu, Hongzhi
    Logan, Zemp
    Alice, Yu
    Scott, Gilbert
    Michael, Poch
    Philippe, Spiess
    Wade, Sexton
    Roger, Li
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [27] Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer
    Bastos, Diogo A.
    Mattedi, Romulo L.
    Barreiro, Rodrigo
    dos Santos, Filipe F.
    Buzatto, Vanessa
    Masotti, Cibele
    Souza, Jussara M.
    de Lima, Mariana Z. T.
    Friguglietti, Giulia W.
    Dzik, Carlos
    Jardim, Denis L. F.
    Coelho, Rafael
    Ribeiro Filho, Leopoldo A.
    Cordeiro, Mauricio D.
    Nahas, William C.
    de Mello, Evandro S.
    Chammas, Roger
    Reis, Luiz Fernando L.
    Bettoni, Fabiana
    Galante, Pedro A. F.
    Camargo, Anamaria A.
    BLADDER CANCER, 2020, 6 (02) : 171 - 186
  • [28] Impact of Smoking Intensity on Outcomes of Patients with Non Muscle Invasive Bladder Cancer Treated by BCG Immunotherapy
    Ajili, Faouzia
    Kourda, Nadia
    Karay, Salma
    Darouiche, Amine
    Chebil, Mohamed
    Boubaker, Samir
    ULTRASTRUCTURAL PATHOLOGY, 2013, 37 (04) : 273 - 277
  • [29] CLINICAL OUTCOMES OF PRIMARY VERSUS SECONDARY NON-MUSCLE INVASIVE BLADDER CANCER
    Yi-Shiou, T.
    Shiu-Dong, C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 289 - 289
  • [30] Clinical Outcomes of Primary Versus Secondary Non-muscle Invasive Bladder Cancer
    Tseng, Y.
    Chung, S.
    UROLOGY, 2012, 80 (03) : S211 - S211
12345